应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNPR Monopar Therapeutics
未开盘 12-27 16:00:00 EST
24.53
-0.81
-3.20%
盘后
23.52
-1.01
-4.12%
19:09 EST
最高
25.50
最低
24.27
成交量
8.95万
今开
24.99
昨收
25.34
日振幅
4.85%
总市值
1.50亿
流通市值
9,617万
总股本
609.85万
成交额
223.03万
换手率
2.28%
流通股本
392.04万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Monopar Therapeutics Inc.盘中异动 股价大跌5.58%报28.27美元
市场透视 · 12-19
Monopar Therapeutics Inc.盘中异动 股价大跌5.58%报28.27美元
Monopar Therapeutics Inc.盘中异动 早盘急速拉升5.44%报26.76美元
市场透视 · 12-16
Monopar Therapeutics Inc.盘中异动 早盘急速拉升5.44%报26.76美元
Monopar Therapeutics Inc.盘中异动 股价大涨5.52%
市场透视 · 12-11
Monopar Therapeutics Inc.盘中异动 股价大涨5.52%
Monopar Therapeutics Inc.股价拉升10.81% 市值涨1327.62万美元
市场透视 · 12-06
Monopar Therapeutics Inc.股价拉升10.81% 市值涨1327.62万美元
Monopar Therapeutics Inc.盘中异动 股价大涨5.17%报21.77美元
市场透视 · 11-29
Monopar Therapeutics Inc.盘中异动 股价大涨5.17%报21.77美元
BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc
路透中文 · 11-20
BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc
BUZZ--美国股票走势-康卡斯特、Wix.com、Flex
Reuters · 11-20
BUZZ--美国股票走势-康卡斯特、Wix.com、Flex
BUZZ-阿斯利康达成协议后,JonesTrading上调了Monopar Therapeutics的PT值
路透中文 · 11-20
BUZZ-阿斯利康达成协议后,JonesTrading上调了Monopar Therapeutics的PT值
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
Reuters · 11-20
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
Monopar Therapeutics Inc.盘中异动 急速上涨6.84%报18.43美元
市场透视 · 11-14
Monopar Therapeutics Inc.盘中异动 急速上涨6.84%报18.43美元
Monopar Therapeutics Inc 报告本季度业绩 - 收益摘要
路透中文 · 11-09
Monopar Therapeutics Inc 报告本季度业绩 - 收益摘要
Monopar Therapeutics Inc.盘中异动 早盘大幅上涨6.17%报16.70美元
市场透视 · 11-08
Monopar Therapeutics Inc.盘中异动 早盘大幅上涨6.17%报16.70美元
Monopar Therapeutics Inc.盘中异动 早盘快速拉升5.60%
市场透视 · 11-04
Monopar Therapeutics Inc.盘中异动 早盘快速拉升5.60%
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.86%
市场透视 · 10-30
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.86%
BUZZ-微型公司 Monopar Therapeutics 因计划发行股票而暴跌
Reuters · 10-29
BUZZ-微型公司 Monopar Therapeutics 因计划发行股票而暴跌
Monopar Therapeutics Inc.盘中异动 快速下挫12.29%报14.85美元
市场透视 · 10-28
Monopar Therapeutics Inc.盘中异动 快速下挫12.29%报14.85美元
Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元
市场透视 · 10-25
Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元
BUZZ-Monopar 因与阿斯利康达成药物许可协议而上涨
Reuters · 10-24
BUZZ-Monopar 因与阿斯利康达成药物许可协议而上涨
Monopar Therapeutics Inc.盘中异动 早盘快速跳水5.81%报5.18美元
市场透视 · 10-21
Monopar Therapeutics Inc.盘中异动 早盘快速跳水5.81%报5.18美元
Monopar Therapeutics Inc.盘中异动 早盘大幅下挫6.93%
市场透视 · 10-09
Monopar Therapeutics Inc.盘中异动 早盘大幅下挫6.93%
加载更多
公司概况
公司名称:
Monopar Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家临床阶段的生物制药公司,专注于为癌症患者开发创新治疗方法。
发行价格:
--
{"stockData":{"symbol":"MNPR","market":"US","secType":"STK","nameCN":"Monopar Therapeutics","latestPrice":24.53,"timestamp":1735333200000,"preClose":25.34,"halted":0,"volume":89543,"hourTrading":{"tag":"盘后","latestPrice":23.52,"preClose":24.53,"latestTime":"19:09 EST","volume":624,"amount":14597.76,"timestamp":1735344560158},"delay":0,"floatShares":3920400,"shares":6098467,"eps":-1.964112,"marketStatus":"未开盘","change":-0.81,"latestTime":"12-27 16:00:00 EST","open":24.99,"high":25.5,"low":24.27,"amount":2230272.214868,"amplitude":0.04854,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.964112,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":0,"adr":0,"listingDate":1576731600000,"exchange":"NASDAQ","adjPreClose":25.34,"preHourTrading":{"tag":"盘前","latestPrice":25.1,"preClose":25.34,"latestTime":"09:29 EST","volume":706,"amount":18376.940666000002,"timestamp":1735309795042},"postHourTrading":{"tag":"盘后","latestPrice":23.52,"preClose":24.53,"latestTime":"19:09 EST","volume":624,"amount":14597.76,"timestamp":1735344560158},"volumeRatio":1.08736577468546},"requestUrl":"/m/hq/s/MNPR","defaultTab":"news","newsList":[{"id":"2492171455","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.58%报28.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492171455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492171455?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:31","pubTimestamp":1734618696,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时31分,Monopar Therapeutics Inc.股票出现异动,股价快速下挫5.58%。截至发稿,该股报28.27美元/股,成交量1344股,换手率0.03%,振幅0.95%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为2.72%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223136984cd919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223136984cd919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2491618449","title":"Monopar Therapeutics Inc.盘中异动 早盘急速拉升5.44%报26.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491618449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491618449?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:26","pubTimestamp":1734362800,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时26分,Monopar Therapeutics Inc.股票出现异动,股价大幅上涨5.44%。截至发稿,该股报26.76美元/股,成交量9635股,换手率0.18%,振幅3.15%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216232641a1f35d43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216232641a1f35d43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2490049728","title":"Monopar Therapeutics Inc.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490049728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490049728?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:37","pubTimestamp":1733852278,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时37分,Monopar Therapeutics Inc.股票出现波动,股价大幅上涨5.52%。截至发稿,该股报23.51美元/股,成交量2.2036万股,换手率0.42%,振幅8.38%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.98%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211013759a1e3e88f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211013759a1e3e88f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2489317162","title":"Monopar Therapeutics Inc.股价拉升10.81% 市值涨1327.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489317162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489317162?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:32","pubTimestamp":1733495534,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时32分,Monopar Therapeutics Inc.股票出现异动,股价快速上涨10.81%。截至发稿,该股报23.27美元/股,成交量5051股,换手率0.10%,振幅0.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223214ab62d4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223214ab62d4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2487056381","title":"Monopar Therapeutics Inc.盘中异动 股价大涨5.17%报21.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487056381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487056381?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:49","pubTimestamp":1732891776,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时49分,Monopar Therapeutics Inc.股票出现异动,股价急速拉升5.17%。截至发稿,该股报21.77美元/股,成交量9008股,换手率0.17%,振幅6.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.25%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224936971aa783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224936971aa783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2484001146","title":"BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2484001146","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484001146?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:57","pubTimestamp":1732118258,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30,道琼斯工业平均指数.DJI下跌0.28%,报43,145.73点。标普500指数.SPX下跌0.78%,报5870.84点;纳斯达克综合指数.IXIC下跌1.16%,报18769.66点。标准普尔 500 指数.PG.INX涨幅前三名是: ** Keysight Technologies Inc KEYS.N,上涨 5.9. nL4N3MR0SH ** 金山云控股有限公司KC.O:BUZZ - 因第三季度亏损小于预期而上涨 nL8N3MR11B ** Silvercorp Metals Inc SVM.N:BUZZ - 在公布可转换债务交易后下跌 nL6N3MR0HA ** Tapestry Inc TPR.N: ** Capri Holdings Ltd CPRI.N:BUZZ - 巴克莱恢复对Tapestry和Capri的覆盖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LMND","BGC","BK4507","BK4555","BK4539","LU1267930490.SGD","DTM","SAGE","LU0310800965.SGD","OMCL","INSP","SPAI","TGT","LU0075056555.USD","WSM","LU1430597077.USD","QDEL","CMI","DAL","F","VKTX","WIX","BK4195","MBIN","GDRX","POWL","SM","FLEX","MNPR","LU0980610538.SGD","BK4554","TPR","LU1280957306.USD","CMCSA","CPRI","LU0094547139.USD","NEM","LU0289961442.SGD","LU0788108826.HKD","CTVA","IE00B1BXHZ80.USD","BK4516","TJX","LU0950375773.USD"],"gpt_icon":1},{"id":"2484112793","title":"BUZZ--美国股票走势-康卡斯特、Wix.com、Flex","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484112793?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113071,"startTime":"0","endTime":"0","summary":"** Wix.com Ltd : BUZZ - 因上调财年营收和预订预期而跳涨 ** GoodRx Holdings Inc : BUZZ - Leerink 表示,该公司是价值被低估最严重的股票之一, 。** 达美航空 : BUZZ - 预测 2025 年收入将实现中等个位数增长,随后上涨。** 金山云控股有限公司 : BUZZ - 因第三季度亏损小于预期而上涨 ** Silvercorp Metals Inc : BUZZ - 在公布可转换债务交易后下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDRX","BK4008","BK4551","LU0057025933.USD","CMCSA","SM","VKTX","SAGE","LU0648001328.SGD","LU0154245756.USD","BK4114","MBIN","MNPR","LU0612318385.USD","CTVA","BGC","RIOT","BK4100","LU0456854461.SGD","COIN","SPAI","BK4198","LU1223083913.SGD","LU0320765489.SGD","NEM","BK4567","LU0630314457.HKD","LU1150488218.USD","LU0289961442.SGD","LU1861559042.SGD","TGT","BK4516","BK4596","LU0124676726.USD","LU0823411888.USD","BK4554","FLEX","LU2098885051.SGD","WIX","CMI","BK4195","LU0788108826.HKD","BK4112","MARA","LU1280957306.USD","QDEL","DAL"],"gpt_icon":1},{"id":"2484186571","title":"BUZZ-阿斯利康达成协议后,JonesTrading上调了Monopar Therapeutics的PT值","url":"https://stock-news.laohu8.com/highlight/detail?id=2484186571","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484186571?lang=zh_cn&edition=full","pubTime":"2024-11-20 20:41","pubTimestamp":1732106497,"startTime":"0","endTime":"0","summary":"11月20日 - ** JonesTrading将药物开发商 Monopar Therapeutics MNPR.O的预测价格从9美元上调至37美元。** 券商称MNPR与阿斯利康AZN.L旗下Alexion公司签署了ALXN-1840治疗威尔森氏病的全球独家许可协议 ** 威尔逊氏病 是一种罕见的遗传病,会导致铜蓄积到有毒水平。** JonesTrading称, ALXN-1840有可能为 MNPR带来 稳定的现金流,为其他开发工作提供资金。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0W3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNPR"],"gpt_icon":0},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":" 路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻 * Apellis Pharmaceuticals Inc :摩根大通将目标价从57美元下调至50美元 * Chord Energy Corp :加拿大皇家银行将目标价从185美元下调至180美元 * Energizer Holdings Inc :摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYN","LU1066053197.SGD","LU0006061336.USD","APLS","AZEK","OCSL","LU0265550946.USD","VERA","FSUN","LOW","BK4187","BRBR","LU2286300806.USD","PIII","ABUS","LU2756315318.SGD","VVV","CRM","AVAV","CHRD","IE00BZ1G4Q59.USD","IE00B19Z8X17.USD","BK4528","TVTX","ANNX","ENR","WMT","NUVL","BBIO","BERY","LU1267930490.SGD","BK4596","LU0310799852.SGD","BK4505","SWTX","CASY","LU1551013425.SGD","BK4086","LU1951198990.SGD","BK4579","NOG","LU1988902786.USD","LU2430703251.USD","LU0528227936.USD","PBF","IIIV","VIR","MNPR","OLMA","LH"],"gpt_icon":0},{"id":"2483683235","title":"Monopar Therapeutics Inc.盘中异动 急速上涨6.84%报18.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483683235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483683235?lang=zh_cn&edition=full","pubTime":"2024-11-14 01:16","pubTimestamp":1731518187,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日01时16分,Monopar Therapeutics Inc.股票出现波动,股价急速拉升6.84%。截至发稿,该股报18.43美元/股,成交量5.8031万股,换手率1.10%,振幅5.16%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114011627abbe3793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114011627abbe3793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"gpt_icon":0},{"id":"2482489805","title":"Monopar Therapeutics Inc 报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482489805","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482489805?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:21","pubTimestamp":1731082873,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics Inc 报告本季度业绩 - 收益摘要Monopar Therapeutics Inc MNPR.OQ报告本季度调整后每股亏损37美分,高于去年同期的每股-70美分。三位分析师对该季度的平均预期是每股亏损 48 美分。Monopar Therapeutics Inc 报告的季度每股收益为亏损 37 美分。Monopar Therapeutics Inc 的股价本季度上涨了 133.4%,今年迄今为止上涨了 824.8%。华尔街对 Monopar Therapeutics Inc 的 12 个月目标价中位数为 15.00 本摘要由 LSEG 11 月 8 日 04:20 p.m. UTC 调制解调器器生成。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"gpt_icon":0},{"id":"2481710176","title":"Monopar Therapeutics Inc.盘中异动 早盘大幅上涨6.17%报16.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481710176","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481710176?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076273,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分,Monopar Therapeutics Inc.股票出现异动,股价大幅上涨6.17%。截至发稿,该股报16.70美元/股,成交量6845股,换手率0.13%,振幅0.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822311398e4176e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822311398e4176e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2480258099","title":"Monopar Therapeutics Inc.盘中异动 早盘快速拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480258099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480258099?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:26","pubTimestamp":1730733984,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时26分,Monopar Therapeutics Inc.股票出现波动,股价快速上涨5.60%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为262.38%、248.79%、64.58%,振幅较大的相关个股有In8Bio, Inc.、Kazia Therapeutics Limited、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为45.39%、39.13%、31.90%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232624a2156143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232624a2156143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2479783726","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783726?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:33","pubTimestamp":1730295198,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时33分,Monopar Therapeutics Inc.股票出现波动,股价急速下跌5.86%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Tharimmune, Inc.、Calcimedica, Inc.、Quince Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1959.72%、101.47%、17.34%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.,振幅分别为51.72%、16.87%、16.26%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021331998e3f66a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021331998e3f66a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"gpt_icon":1},{"id":"2479450889","title":"BUZZ-微型公司 Monopar Therapeutics 因计划发行股票而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2479450889","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479450889?lang=zh_cn&edition=full","pubTime":"2024-10-29 04:42","pubTimestamp":1730148141,"startTime":"0","endTime":"0","summary":" 10月28日 - ** Monopar Therapeutics 公布股票募集计划后,盘后股价下跌约18%,至14.65美元。** 该公司宣布在尽力而为的基础上发行 股票;交易规模未披露** 该公司计划将募集资金净额用于一般用途,包括研发、临床试验支出等。** 该公司有 390 万股已发行股票,市值约为 7000 万美元,自由流通股约为 200 万股。** 罗德曼-伦肖公司股票发行的独家配售代理","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"25c5a4130559b7553526084ea6d96935","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","LENZ","BK4139"],"gpt_icon":1},{"id":"2478860394","title":"Monopar Therapeutics Inc.盘中异动 快速下挫12.29%报14.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478860394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478860394?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122267,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分,Monopar Therapeutics Inc.股票出现波动,股价大幅下跌12.29%。截至发稿,该股报14.85美元/股,成交量24.3437万股,换手率6.92%,振幅1.54%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821310795bd74e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821310795bd74e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"gpt_icon":1},{"id":"2478925933","title":"Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478925933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478925933?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863064,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分,Monopar Therapeutics Inc.股票出现异动,股价大幅跳水31.11%。截至发稿,该股报22.50美元/股,成交量64.5707万股,换手率18.34%,振幅1.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":1},{"id":"2477689645","title":"BUZZ-Monopar 因与阿斯利康达成药物许可协议而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2477689645","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477689645?lang=zh_cn&edition=full","pubTime":"2024-10-24 19:29","pubTimestamp":1729769396,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 10月24日 - ** 药物开发商Monopar Therapeutics的 股价盘前上涨13%,报5.25美元** 公司与阿斯利康 旗下的Alexion公司签署了 (link) 协议,获得了AZN公司正在测试的治疗威尔逊病的实验性药物的许可,威尔逊病是一种罕见的遗传病,会导致有毒铜含量的积累。** Monopar 将负责未来的全球开发和药物商业化活动** 根据交易条款,Monopar 将以现金和 Monopar 股权的形式向 Alexion 支付预付款。** 截至上一交易日收盘,Monopar 的股价已上涨了两倍多。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2236285917.USD","BK4568","LU2462157665.USD","LU2417539215.USD","LU1829250122.USD","BK4588","LU2456880835.USD","MNPR","LU0889565916.HKD","AZN","LU0320765992.SGD","LU0109394709.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2477865815","title":"Monopar Therapeutics Inc.盘中异动 早盘快速跳水5.81%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477865815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477865815?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:33","pubTimestamp":1729517605,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时33分,Monopar Therapeutics Inc.股票出现波动,股价快速下跌5.81%。截至发稿,该股报5.18美元/股,成交量3515股,换手率0.10%,振幅2.07%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121332698e3d83c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121332698e3d83c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2474226857","title":"Monopar Therapeutics Inc.盘中异动 早盘大幅下挫6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474226857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474226857?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:40","pubTimestamp":1728481221,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时40分,Monopar Therapeutics Inc.股票出现异动,股价急速下挫6.93%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大,Windtree Therapeutics, Inc.、Aditxt, Inc.、Gri Bio, Inc.较为活跃,换手率分别为631.15%、118.72%、43.38%,振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.,振幅分别为39.02%、22.69%、12.50%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092140219719f436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092140219719f436&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.monopartx.com","stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":0.185},{"period":"3month","weight":2.6233},{"period":"6month","weight":5.7196},{"period":"1year","weight":11.948},{"period":"ytd","weight":13.4209}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家临床阶段的生物制药公司,专注于为癌症患者开发创新治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.132183},{"month":2,"riseRate":0.4,"avgChangeRate":0.185715},{"month":3,"riseRate":0,"avgChangeRate":-0.262897},{"month":4,"riseRate":0.2,"avgChangeRate":-0.066127},{"month":5,"riseRate":0.2,"avgChangeRate":-0.05402},{"month":6,"riseRate":0.6,"avgChangeRate":0.028808},{"month":7,"riseRate":0,"avgChangeRate":-0.087409},{"month":8,"riseRate":0,"avgChangeRate":-0.156699},{"month":9,"riseRate":0.2,"avgChangeRate":0.302692},{"month":10,"riseRate":0.4,"avgChangeRate":0.257786},{"month":11,"riseRate":0.6,"avgChangeRate":0.056354},{"month":12,"riseRate":0.6,"avgChangeRate":0.033409}],"exchange":"NASDAQ","name":"Monopar Therapeutics","nameEN":"Monopar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Monopar Therapeutics,MNPR,Monopar Therapeutics股票,Monopar Therapeutics股票老虎,Monopar Therapeutics股票老虎国际,Monopar Therapeutics行情,Monopar Therapeutics股票行情,Monopar Therapeutics股价,Monopar Therapeutics股市,Monopar Therapeutics股票价格,Monopar Therapeutics股票交易,Monopar Therapeutics股票购买,Monopar Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}